Predictors of acromial and scapular stress fracture after reverse shoulder arthroplasty: a study by the ASES Complications of RSA Multicenter Research Group.


Journal

Journal of shoulder and elbow surgery
ISSN: 1532-6500
Titre abrégé: J Shoulder Elbow Surg
Pays: United States
ID NLM: 9206499

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 13 10 2020
revised: 31 01 2021
accepted: 08 02 2021
pubmed: 8 3 2021
medline: 22 9 2021
entrez: 7 3 2021
Statut: ppublish

Résumé

Acromial (ASF) and scapular spine (SSF) stress fractures are well-recognized complications of reverse shoulder arthroplasty (RSA), but much of the current data are derived from single-center or single-implant studies with limited generalizability. This study from the American Shoulder and Elbow Surgeons (ASES) Complications of Reverse Shoulder Arthroplasty Multicenter Research Group determined the incidence of ASF/SSF after RSA and identified preoperative patient characteristics associated with their occurrence. Fifteen institutions including 21 ASES members across the United States participated in this study. Patients undergoing either primary or revision RSA between January 2013 and June 2019 with a minimum 3-month follow-up were included. All definitions and inclusion criteria were determined using the Delphi method, an iterative survey process involving all primary investigators. Consensus was achieved when at least 75% of investigators agreed on each aspect of the study protocol. Only symptomatic ASF/SSF diagnosed by radiograph or computed tomography were considered. Multivariable logistic regression was performed to identify factors associated with ASF/SSF development. We identified 6755 RSAs with an average follow-up of 19.8 months (range, 3-94). The total stress fracture incidence rate was 3.9% (n = 264), of which 3.0% (n = 200) were ASF and 0.9% (n = 64) were SSF. Fractures occurred at an average 8.2 months (0-64) following RSA with 21.2% (n = 56) following a trauma. Patient-related factors independently predictive of ASF were chronic dislocation (odds ratio [OR] 3.67, P = .04), massive rotator cuff tear without arthritis (OR 2.51, P < .01), rotator cuff arthropathy (OR 2.14, P < .01), self-reported osteoporosis (OR 2.21, P < .01), inflammatory arthritis (OR 2.18, P < .01), female sex (OR 1.51, P = .02), and older age (OR 1.02 per 1-year increase, P = .02). Factors independently associated with the development of SSF included osteoporosis (OR 2.63, P < .01), female sex (OR 2.34, P = .01), rotator cuff arthropathy (OR 2.12, P = .03), and inflammatory arthritis (OR 2.05, P = .03). About 1 in 26 patients undergoing RSA will develop a symptomatic ASF or SSF, more frequently within the first year of surgery. Our results indicate that severe rotator cuff disease may play an important role in the occurrence of stress fractures following RSA. This information can be used to counsel patients about potential setbacks in recovery, especially among older women with suboptimal bone health. Strategies for prevention of ASF and SSF in these at-risk patients warrant further study. A follow-up study evaluating the impact of prosthetic factors on the incidence rates of ASF and SSF may prove highly valuable in the decision-making process.

Sections du résumé

BACKGROUND BACKGROUND
Acromial (ASF) and scapular spine (SSF) stress fractures are well-recognized complications of reverse shoulder arthroplasty (RSA), but much of the current data are derived from single-center or single-implant studies with limited generalizability. This study from the American Shoulder and Elbow Surgeons (ASES) Complications of Reverse Shoulder Arthroplasty Multicenter Research Group determined the incidence of ASF/SSF after RSA and identified preoperative patient characteristics associated with their occurrence.
METHOD METHODS
Fifteen institutions including 21 ASES members across the United States participated in this study. Patients undergoing either primary or revision RSA between January 2013 and June 2019 with a minimum 3-month follow-up were included. All definitions and inclusion criteria were determined using the Delphi method, an iterative survey process involving all primary investigators. Consensus was achieved when at least 75% of investigators agreed on each aspect of the study protocol. Only symptomatic ASF/SSF diagnosed by radiograph or computed tomography were considered. Multivariable logistic regression was performed to identify factors associated with ASF/SSF development.
RESULTS RESULTS
We identified 6755 RSAs with an average follow-up of 19.8 months (range, 3-94). The total stress fracture incidence rate was 3.9% (n = 264), of which 3.0% (n = 200) were ASF and 0.9% (n = 64) were SSF. Fractures occurred at an average 8.2 months (0-64) following RSA with 21.2% (n = 56) following a trauma. Patient-related factors independently predictive of ASF were chronic dislocation (odds ratio [OR] 3.67, P = .04), massive rotator cuff tear without arthritis (OR 2.51, P < .01), rotator cuff arthropathy (OR 2.14, P < .01), self-reported osteoporosis (OR 2.21, P < .01), inflammatory arthritis (OR 2.18, P < .01), female sex (OR 1.51, P = .02), and older age (OR 1.02 per 1-year increase, P = .02). Factors independently associated with the development of SSF included osteoporosis (OR 2.63, P < .01), female sex (OR 2.34, P = .01), rotator cuff arthropathy (OR 2.12, P = .03), and inflammatory arthritis (OR 2.05, P = .03).
CONCLUSION CONCLUSIONS
About 1 in 26 patients undergoing RSA will develop a symptomatic ASF or SSF, more frequently within the first year of surgery. Our results indicate that severe rotator cuff disease may play an important role in the occurrence of stress fractures following RSA. This information can be used to counsel patients about potential setbacks in recovery, especially among older women with suboptimal bone health. Strategies for prevention of ASF and SSF in these at-risk patients warrant further study. A follow-up study evaluating the impact of prosthetic factors on the incidence rates of ASF and SSF may prove highly valuable in the decision-making process.

Identifiants

pubmed: 33677115
pii: S1058-2746(21)00149-X
doi: 10.1016/j.jse.2021.02.008
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2296-2305

Informations de copyright

Copyright © 2021 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Auteurs

Kuhan A Mahendraraj (KA)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA; Boston Sports and Shoulder Center, Waltham, MA, USA.

Joseph Abboud (J)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

April Armstrong (A)

Penn State Bone and Joint Institute, Hershey, PA, USA.

Luke Austin (L)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

Tyler Brolin (T)

Department of Orthopaedic Surgery and Biomedical Engineering, Campbell Clinic, Memphis, TN, USA.

Vahid Entezari (V)

Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Lisa Friedman (L)

Midwest Orthopaedics at RUSH, Chicago, IL, USA.

Grant E Garrigues (GE)

Midwest Orthopaedics at RUSH, Chicago, IL, USA.

Brian Grawe (B)

University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Lawrence Gulotta (L)

Hospital for Special Surgery, New York City, NY, USA.

Michael Gutman (M)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

Paul-Anthony Hart (PA)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA; Boston Sports and Shoulder Center, Waltham, MA, USA.

Rhett Hobgood (R)

Mississippi Sports Medicine and Orthopaedic Surgery, Jackson, MS, USA.

John G Horneff (JG)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

Joseph Iannotti (J)

Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Michael Khazzam (M)

UT Southwestern Medical Center, Dallas, TX, USA.

Joseph King (J)

Department of Orthopaedics and Rehabilitation, University of Florida College of Medicine, Gainesville, FL, USA.

Michael A Kloby (MA)

University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Margaret Knack (M)

Department of Orthopaedic Surgery and Biomedical Engineering, Campbell Clinic, Memphis, TN, USA.

Jon Levy (J)

Holy Cross Orthopedic Institute, Fort Lauderdale, FL, USA.

Anand Murthi (A)

MedStar Union Memorial Hospital, Baltimore, MD, USA.

Surena Namdari (S)

Rothman Orthopaedic Institute, Philadelphia, PA, USA.

Laurence Okeke (L)

Hospital for Special Surgery, New York City, NY, USA.

Randall Otto (R)

St. Louis University Care Physician Group, St. Louis University School of Medicine, St. Louis, MO, USA.

Douglas E Parsell (DE)

Mississippi Sports Medicine and Orthopaedic Surgery, Jackson, MS, USA.

Teja Polisetty (T)

Holy Cross Orthopedic Institute, Fort Lauderdale, FL, USA.

Padmavathi Ponnuru (P)

Penn State Bone and Joint Institute, Hershey, PA, USA.

Eric Ricchetti (E)

Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Robert Tashjian (R)

University of Utah School of Medicine, Salt Lake City, UT, USA.

Thomas Throckmorton (T)

Department of Orthopaedic Surgery and Biomedical Engineering, Campbell Clinic, Memphis, TN, USA.

Clay Townsend (C)

Department of Orthopaedics and Rehabilitation, University of Florida College of Medicine, Gainesville, FL, USA.

Melissa Wright (M)

MedStar Union Memorial Hospital, Baltimore, MD, USA.

Thomas Wright (T)

Department of Orthopaedics and Rehabilitation, University of Florida College of Medicine, Gainesville, FL, USA.

Zachary Zimmer (Z)

George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Mariano E Menendez (ME)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.

Andrew Jawa (A)

Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA; Boston Sports and Shoulder Center, Waltham, MA, USA. Electronic address: andrewjawa@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH